Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2026
Half of all clinical trials in Europe do not report results as required by law
From Mercosur to US Tariffs: Access to Medicines and the EU’s Trade Challenge
Farewell to the SHARP Project?
Alarming fall in access to SRH supplies in Kenya
2025
Period Tracking Apps and Consumer Protections
Championing Adolescent SRH in Zambia – A picture essay
2024
EMA’s Brave Approach Governing AI in Medicines Regulation
Civil society letter calls for European Parliament to support global access to medical tools
2023
AI and Medicines: A Year in Focus
2022
HAI and Partners Launch New SRH Project
Artificial Intelligence Act – A long awaited report surfaces
EU rushing WTO members to adopt weak waiver text
Risks and Harms from Health-related AI
Make good on access to medicine commitments HAI asks new Dutch Health Minister
2021
Transparency: Bringing the Issue to Life
Working with the European Parliament
COVID-19: European Commission gives lacklustre response to legitimate civil society concerns
European Commission is offering no meaningful solutions for equitable access
Clinical Trial Data and the Risk of Bias
Getting Hack to Reality
A Pandemic Response Lacking Moral Leadership
MPs and MEPs Call for TRIPS Waiver
Over 100 MEPs call for a TRIPS Waiver
Access to Medicines in Europe
2020